Advocacy - Miscellaneous

CLSA Letter To Reps. Brooks And Eshoo In Support Of PAHPAI Act of 2018 – July 2018

July 16, 2018

The Honorable Susan Brooks
1505 Longworth House Office Building
Washington, DC 20515
The Honorable Anna G. Eshoo
241 Cannon House Office Building
Washington, DC 20515

Dear Representatives Brooks and Eshoo:

On behalf of California Life Sciences Association (CLSA) – the statewide public policy organization representing California’s leading life science innovators, including medical device, diagnostic, biotechnology and pharmaceutical companies, research universities and private, non‐profit institutes, and venture capital firms – I am writing to express our support for H.R. 6378, the Pandemic and All Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2018, your legislation that will strengthen and improve our national preparedness and response for public health emergencies, and accelerate medical countermeasure research and development. Thank you for your leadership on this critically important issue.

As you know, the recent Ebola and Zika outbreaks and ongoing threats from terrorist organizations like ISIS have repeatedly exposed our nation’s continued vulnerability to bioterror and pandemic threats, demonstrating the need for robust biodefense preparedness. Robust, long‐term funding, and strong and sustained public‐private partnerships remain critical in ensuring a well‐funded, well‐coordinated, swift and effective response from all stakeholders. This includes, critically, a robust statutory framework for securing our nation from chemical, biological, radiological, and nuclear (CBRN) threats, as well as from pandemic influenza (PI), antimicrobial resistance (AMR), and emerging infectious diseases (EID).